Investing in AcelRx Pharmaceuticals, Inc. (ACRX)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)0.47-45
Intrinsic value (DCF)0.47-45
Graham-Dodd Method28.323193
Graham Formula0.00-100

Company description

AcelRx Pharmaceuticals, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes DSUVIA, DZUVEO, Zalviso, ARX-02 and ARX-03. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.